David Westenberg

Q: What is David Westenberg's success rate?

David Westenberg currently has a success rate of 98.25266534065653.

Q: What is the average return of David Westenberg's calls?

Their stock ratings have generated an average return of 28.52339249229272.

Piper Sandler | Healthcare

David Westenberg is an analyst from Piper Sandler specializing in the Healthcare sector. Ranked #497 out of 4765 analysts, they have issued 51 stock ratings with a success rate of 98.25% and an average return of 28.52%.

David Westenberg has a well-established track record, with 51 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 98.25% and an average return of 28.52%, underscoring their expertise and ability to identify winning opportunities for investors.

#497

Out of 4765

Total Ratings

+98.25%

Success Rate

+28.52%

Average Return

Recent Ratings Analysis

TEM

Buy

Sep 01, 2026

Target

$76.00

Current

$64.66

Performance

3.84%

David Westenberg rated TEM as Overweight on Sep 01, 2026, setting a price target of 76. Shares have remained stable near 64.66, leaving the 76 target still in play.

MYGN

Sell

Sep 01, 2026

Target

$5.45

Current

$3.23

Performance

1.57%

On Sep 01, 2026, MYGN was given a Underweight rating by David Westenberg, with a target price of 5.45. The stock traded sideways with only a 1.57% move, leaving the Sell case unresolved.

TWST

Buy

Aug 05, 2026

Target

$115.00

Current

$128.71

Performance

11.91%

TWST received a Overweight rating from David Westenberg on Aug 05, 2026, aiming for 115. Momentum has favored the Buy call, with shares climbing from 128.71 to 128.71, rewarding those who trusted the recommendation.

LH

Hold

Aug 04, 2026

Target

$309.00

Current

$331.50

Performance

6.13%

On Aug 04, 2026, David Westenberg published a Neutral outlook on LH, with a target of 309. The Hold call missed some of the bullish momentum as shares advanced toward 309.

VCYT

Buy

Aug 04, 2026

Target

$54.00

Current

$44.67

Performance

-3.75%

David Westenberg on Aug 04, 2026 assigned VCYT a Overweight rating, with a price target of 54. The recommendation remains pending validation as shares consolidate around 44.67.

GH

Buy

Aug 04, 2026

Target

$193.00

Current

$161.04

Performance

0.78%

On Aug 04, 2026, David Westenberg reaffirmed GH with a Overweight rating, targeting 193. Market indecision has kept the 193 target in a holding pattern.

FLGT

Hold

Aug 04, 2026

Target

$19.00

Current

$19.65

Performance

5.93%

FLGT was rated Neutral by David Westenberg on Aug 04, 2026, with a price objective of 19. Despite caution, upside momentum rewarded risk-takers with gains to 19.65.

ADPT

Buy

Aug 04, 2026

Target

$27.50

Current

$24.57

Performance

0.08%

On Aug 04, 2026, David Westenberg initiated coverage on ADPT with a Overweight rating and target of 27.5. Neutral price movement of 0.08% leaves room for interpretation.

NEOG

Hold

Aug 03, 2026

Target

$13.00

Current

$11.64

Performance

-2.18%

David Westenberg issued a Neutral recommendation for NEOG on Aug 03, 2026, price target set at 13. The rating was appropriate for a consolidating market trading near 11.64.

ILMN

Buy

Aug 03, 2026

Target

$225.00

Current

$221.66

Performance

11.86%

On Aug 03, 2026, ILMN was evaluated by David Westenberg, who gave a Overweight rating and target of 225. This case illustrates how a timely bullish rating can translate into tangible gains of 11.86%.

TMO

Hold

Jul 27, 2026

Target

$600.00

Current

$618.43

Performance

10.53%

David Westenberg rated TMO as Neutral on Jul 27, 2026, setting a price target of 600. Despite the Hold call, shares climbed 10.53% to 618.43, revealing unexpected momentum.

TXG

Hold

Jul 01, 2026

Target

$42.00

Current

$63.22

Performance

61.90%

On Jul 01, 2026, TXG was given a Neutral rating by David Westenberg, with a target price of 42. The stock rallied from 63.22 to 63.22 after the Hold rating, surprising to the upside.

WGS

Buy

Jun 23, 2026

Target

$63.00

Current

$87.39

Performance

50.46%

WGS received a Overweight rating from David Westenberg on Jun 23, 2026, aiming for 63. Momentum has favored the Buy call, with shares climbing from 87.39 to 87.39, rewarding those who trusted the recommendation.

TECH

Hold

Jun 11, 2026

Target

$65.00

Current

$72.45

Performance

34.12%

On Jun 11, 2026, David Westenberg published a Neutral outlook on TECH, with a target of 65. The Hold call missed some of the bullish momentum as shares advanced toward 65.

A

Hold

Jun 11, 2026

Target

$150.00

Current

$149.92

Performance

15.72%

David Westenberg on Jun 11, 2026 assigned A a Neutral rating, with a price target of 150. Shares outperformed expectations, climbing 15.72% despite the neutral view.

DHR

Hold

Jun 11, 2026

Target

$200.00

Current

$210.96

Performance

16.69%

On Jun 11, 2026, David Westenberg reaffirmed DHR with a Neutral rating, targeting 200. Market strength beyond 210.96 went further than the conservative outlook suggested.

WAT

Hold

Jun 11, 2026

Target

$400.00

Current

$413.56

Performance

14.96%

WAT was rated Neutral by David Westenberg on Jun 11, 2026, with a price objective of 400. Despite caution, upside momentum rewarded risk-takers with gains to 413.56.

GRAL

Hold

May 06, 2026

Target

$56.00

Current

$80.62

Performance

28.48%

On May 06, 2026, David Westenberg initiated coverage on GRAL with a Neutral rating and target of 56. The Hold stance underestimated the stock’s strength as it gained 28.48%.

CAI

Hold

Apr 10, 2026

Target

$21.00

Current

$25.32

Performance

40.28%

David Westenberg issued a Neutral recommendation for CAI on Apr 10, 2026, price target set at 21. A neutral call gave way to stronger-than-expected performance, closing in on 21.

NEO

Buy

Feb 24, 2026

Target

$13.00

Current

$17.46

Performance

80.93%

On Feb 24, 2026, NEO was evaluated by David Westenberg, who gave a Overweight rating and target of 13. This case illustrates how a timely bullish rating can translate into tangible gains of 80.93%.

IDXX

Hold

Feb 09, 2026

Target

$750.00

Current

$529.29

Performance

-17.27%

David Westenberg rated IDXX as Neutral on Feb 09, 2026, setting a price target of 750. The cautious Hold call aligned with subsequent weakness, as shares slipped 17.27%.

ZTS

Hold

Jan 22, 2026

Target

$135.00

Current

$76.29

Performance

-38.67%

On Jan 22, 2026, ZTS was given a Neutral rating by David Westenberg, with a target price of 135. The rating provided protection from downside risk as the stock fell to 76.29.

ELAN

Buy

Jan 22, 2026

Target

$30.00

Current

$24.41

Performance

-2.01%

ELAN received a Overweight rating from David Westenberg on Jan 22, 2026, aiming for 30. Price action was muted, as shares hovered around 24.41 despite the bullish outlook.

BLLN

Buy

Dec 01, 2025

Target

$150.00

Current

$99.50

Performance

-11.98%

On Dec 01, 2025, David Westenberg published a Overweight outlook on BLLN, with a target of 150. Market action contradicted the Buy thesis, as shares slipped to 99.5.

EXAS

Buy

Nov 11, 2025

Target

$80.00

Current

$104.91

Performance

55.42%

David Westenberg on Nov 11, 2025 assigned EXAS a Overweight rating, with a price target of 80. The Buy call aligned well with market performance, producing a gain of 55.42%.

PACB

Hold

Nov 11, 2025

Target

$2.00

Current

$1.30

Performance

-30.11%

On Nov 11, 2025, David Westenberg reaffirmed PACB with a Neutral rating, targeting 2. The Hold stance reflected market caution that was later justified.

NTRA

Buy

Nov 11, 2025

Target

$230.00

Current

$327.67

Performance

58.51%

NTRA was rated Overweight by David Westenberg on Nov 11, 2025, with a price objective of 230. A bullish response from the market helped close the gap of -97.67 to the target.

CTKB

Buy

Nov 11, 2025

Target

$7.50

Current

$4.70

Performance

-1.88%

On Nov 11, 2025, David Westenberg initiated coverage on CTKB with a Overweight rating and target of 7.5. Neutral price movement of -1.88% leaves room for interpretation.

DGX

Hold

Oct 27, 2025

Target

$200.00

Current

$239.40

Performance

32.81%

David Westenberg issued a Neutral recommendation for DGX on Oct 27, 2025, price target set at 200. A neutral call gave way to stronger-than-expected performance, closing in on 200.

AKYA

Buy

Nov 19, 2024

Target

$3.00

Current

$1.29

Performance

-40.28%

On Nov 19, 2024, AKYA was evaluated by David Westenberg, who gave a Overweight rating and target of 3. Investors saw limited payoff as shares fell short of the 3 target.

Frequency Asked Questions

Who is David Westenberg?

David Westenberg is an analyst from Piper Sandler specializing in the Healthcare sector.

What is David Westenberg's success rate?

David Westenberg currently has a success rate of +98.25%.

How many ratings has David Westenberg issued?

David Westenberg has issued 51 stock ratings so far.

What is the average return of David Westenberg's calls?

Their stock ratings have generated an average return of +28.52%.

What is David Westenberg's ranking?

David Westenberg is ranked #497 out of 4765 analysts.

What types of ratings does David Westenberg give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Westenberg?

You can follow David Westenberg by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Westenberg?

Their latest rating was a Buy on TEM issued on 2026-09-01.